Kewal K. Jain
Jain PharmaBiotech
Biotechnology
Blaesiring 7
Basel
Name/email consistency: high
- Advances in use of functionalized carbon nanotubes for drug design and discovery. Jain, K.K. Expert. Opin. Drug. Discov (2012)
- Personalized cancer vaccines. Jain, K.K. Expert. Opin. Biol. Ther (2010)
- Cell therapy for CNS trauma. Jain, K.K. Mol. Biotechnol. (2009)
- Personalized clinical laboratory diagnostics. Jain, K.K. Adv. Clin. Chem (2009)
- The role of nanobiotechnology in drug discovery. Jain, K.K. Adv. Exp. Med. Biol. (2009)
- Gene therapy for pain. Jain, K.K. Expert. Opin. Biol. Ther (2008)
- Cell therapy for pain. Jain, K.K. Expert. Opin. Biol. Ther (2008)
- Pain management--Visiongain's fourth annual conference. Exploring recent developments in pain therapy. Jain, K. IDrugs (2008)
- Recent advances in nanooncology. Jain, K.K. Technol. Cancer Res. Treat. (2008)
- Stability and delivery of RNA via the gastrointestinal tract. Jain, K.K. Current. Drug. Delivery (2008)
- Nanomedicine: application of nanobiotechnology in medical practice. Jain, K.K. Med. Princ. Pract (2008)
- Neuroprotection in traumatic brain injury. Jain, K.K. Drug Discov. Today (2008)
- Current challenges and future prospects in management of neuropathic pain. Jain, K.K. Expert. Rev. Neurother (2008)
- Innovations, challenges and future prospects of oncoproteomics. Jain, K.K. Mol. Oncol (2008)
- Nanobiotechnology-based drug delivery to the central nervous system. Jain, K.K. Neurodegener. Dis (2007)
- Use of nanoparticles for drug delivery in glioblastoma multiforme. Jain, K.K. Expert. Rev. Neurother (2007)
- Applications of nanobiotechnology in clinical diagnostics. Jain, K.K. Clin. Chem. (2007)
- Recent advances in clinical oncoproteomics. Jain, K.K. J. BUON (2007)
- Cancer biomarkers: current issues and future directions. Jain, K.K. Curr. Opin. Mol. Ther. (2007)
- Nanoparticles as targeting ligands. Jain, K.K. Trends Biotechnol. (2006)
- Future prospects for the cure of brain cancer. Jain, K.K. Technol. Cancer Res. Treat. (2006)
- Commercial potential of RNAi. Jain, K.K. Mol. Biosyst (2006)
- Challenges of drug discovery for personalized medicine. Jain, K.K. Curr. Opin. Mol. Ther. (2006)
- Ethical and regulatory aspects of embryonic stem cell research. Jain, K.K. Expert. Opin. Biol. Ther (2005)
- Nanotechnology in clinical laboratory diagnostics. Jain, K.K. Clin. Chim. Acta (2005)
- Nanotechnology-based drug delivery for cancer. Jain, K.K. Technol. Cancer Res. Treat. (2005)
- Personalised medicine for cancer: from drug development into clinical practice. Jain, K.K. Expert. Opin. Pharmacother (2005)
- The role of nanobiotechnology in drug discovery. Jain, K.K. Drug Discov. Today (2005)
- IBC's 4th Annual Conference on Molecular Diagnostics. September 13-14, 2005, Convention and Expo Center, Boston, MA, USA. Jain, K.K. Expert Rev. Mol. Diagn. (2005)
- Applications of AmpliChip CYP450. Jain, K.K. Mol. Diagn. (2005)
- Role of nanobiotechnology in developing personalized medicine for cancer. Jain, K.K. Technol. Cancer Res. Treat. (2005)
- Applications and commercial potential of RNAi. Jain, K.K. IDrugs (2005)
- Proteomics and drug discovery. Jain, K.K. Contrib. Nephrol (2004)
- Modulators of nicotinic acetylcholine receptors as analgesics. Jain, K.K. Curr. Opin. Investig. Drugs (2004)
- RNAi and siRNA in target validation. Jain, K.K. Drug Discov. Today (2004)
- RNAi and siRNA. Jain, K.K. Pharmacogenomics (2004)
- Role of pharmacoproteomics in the development of personalized medicine. Jain, K.K. Pharmacogenomics (2004)
- Applications of biochips: from diagnostics to personalized medicine. Jain, K.K. Curr. Opin. Drug. Discov. Devel (2004)
- Current status of fluorescent in-situ hybridisation. Jain, K.K. Med. Device. Technol (2004)
- Lab-on-a-chip and microarrays: discovery and development. Jain, K.K. Pharmacogenomics (2003)
- Nanodiagnostics: application of nanotechnology in molecular diagnostics. Jain, K.K. Expert Rev. Mol. Diagn. (2003)
- Current status of molecular biosensors. Jain, K.K. Med. Device. Technol (2003)
- Proteomics and protein arrays Europa. Jain, K.K. Pharmacogenomics (2003)
- Information on commercial aspects of pharmacogenomics. Jain, K.K. Pharmacogenomics (2003)
- Post-genomic applications of lab-on-a-chip and microarrays. Jain, K.K. Trends Biotechnol. (2002)
- Using proteomics to identify targets and validate leads. Jain, K.K. Trends Biotechnol. (2002)
- From molecular diagnostics to personalized medicine. The IBC Workshop, London, UK, 1st May, 2002. Jain, K.K. Expert Rev. Mol. Diagn. (2002)
- Recent advances in oncoproteomics. Jain, K.K. Curr. Opin. Mol. Ther. (2002)
- Stem cell technologies in regenerative medicine. Jain, K.K. Expert. Opin. Biol. Ther (2002)
- Ethical and regulatory aspects of embryonic stem cell research. Jain, K.K. Expert. Opin. Biol. Ther (2002)
- Current trends in molecular diagnostics. Jain, K.K. Med. Device. Technol (2002)
- New routes for drug discovery. Jain, K.K. Drug Discov. Today (2002)
- Personalized medicine. Jain, K.K. Curr. Opin. Mol. Ther. (2002)
- Proteomics-based anticancer drug discovery and development. Jain, K.K. Technol. Cancer Res. Treat. (2002)
- Role of proteomics in diagnosis of cancer. Jain, K.K. Technol. Cancer Res. Treat. (2002)
- Cambridge Healthtech Institute's Third Annual Conference on Lab-on-a-Chip and Microarrays. 22-24 January 2001, Zurich, Switzerland. Jain, K.K. Pharmacogenomics (2001)
- Applied neurogenomics. Jain, K.K. Pharmacogenomics (2001)
- Use of bacteria as anticancer agents. Jain, K.K. Expert. Opin. Biol. Ther (2001)
- Will neurogenomics revolutionize neurotherapeutics?. Jain, K. Expert. Rev. Neurother (2001)
- Biotechnological applications of lab-chips and microarrays. Jain, K.K. Trends Biotechnol. (2000)
- Neuroprotection in cerebrovascular disease. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- Evaluation of mitoxantrone for the treatment of multiple sclerosis. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- Evaluation of memantine for neuroprotection in dementia. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- An assessment of levetiracetam as an anti-epileptic drug. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- An evaluation of intrathecal ziconotide for the treatment of chronic pain. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- Evaluation of intravenous parecoxib for the relief of acute post-surgical pain. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- An assessment of iloperidone for the treatment of schizophrenia. Jain, K.K. Expert. Opin. Investig. Drugs (2000)
- An assessment of zonisamide as an anti-epileptic drug. Jain, K.K. Expert. Opin. Pharmacother (2000)
- Applications of biochip and microarray systems in pharmacogenomics. Jain, K.K. Pharmacogenomics (2000)
- Applications of proteomics in oncology. Jain, K.K. Pharmacogenomics (2000)